Physician profile
Salman Dar
NPI 1700272408
$1,692.72
in general payments reported to CMS, 2019-2025
13 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $415 · 2023: $275 · 2024: $275 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,115.47 | 2021-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Tarsus Pharmaceuticals, INC. | $211.03 | 2024-2025 | Xdemvy |
| Rxsight INC | $53.03 | 2022 | |
| Bausch & Lomb Americas INC. | $47.98 | 2024-2025 | Xiidra, Miebo |
| Dompe US, INC. | $42.67 | 2021-2025 | Oxervate |
| Glaukos Corporation | $41.95 | 2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $41.88 | 2022 | |
| Abbvie INC. | $36.95 | 2022 | |
| Ani Pharmaceuticals, INC. | $27.87 | 2025 | Iluvien |
| New World Medical,INC. | $23.48 | 2025 | Via360, Clearpath, Streamline |
| Johnson & Johnson Surgical Vision, INC. | $21.34 | 2022 | |
| Sight Sciences, INC. | $16.38 | 2024 | Omni Surgical System |
| Oyster Point Pharma, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Dar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.